Waghchoure Simon, Bradley Robert, Sorrell McKenzie, Arya Rohan
Department of Pulmonary and Critical Care Medicine, University of South Carolina School of MedicineColumbiaSouth Carolina.
Department of Pathology, University of South Carolina School of MedicineColumbiaSouth Carolina.
Proc (Bayl Univ Med Cent). 2019 Jun 10;32(3):408-410. doi: 10.1080/08998280.2019.1612688. eCollection 2019 Jul.
Inflammatory myofibroblastic tumor, previously named inflammatory pseudotumor, is a biologically borderline mesenchymal neoplasm often associated with an inflammatory infiltrate. The incidence of inflammatory myofibroblastic tumor has been found to range from 0.04% to 1.2%, with endobronchial cases being extremely rare. The treatment of choice for pulmonary inflammatory myofibroblastic tumor is complete surgical resection. However, disease recurrence has been reported. Modalities used to treat recurrent and metastatic disease include surgical resection and corticosteroids. We present a case of recurrent endobronchial inflammatory myofibroblastic tumor that was successfully treated endoscopically with rigid bronchoscopy and laser debulking without need for further surgical intervention.
炎性肌纤维母细胞瘤，以前称为炎性假瘤，是一种生物学行为介于良恶性之间的间叶性肿瘤，常伴有炎性浸润。炎性肌纤维母细胞瘤的发病率为0.04%至1.2%，支气管内病例极为罕见。肺炎性肌纤维母细胞瘤的首选治疗方法是完整手术切除。然而，已有疾病复发的报道。用于治疗复发和转移性疾病的方法包括手术切除和使用皮质类固醇。我们报告一例复发性支气管内炎性肌纤维母细胞瘤，通过硬质支气管镜和激光减瘤术进行内镜治疗成功，无需进一步手术干预。
